BridgeMD
New treatment option for Allogenic Bone Marrow Transplantation
Official title Rehab Study for alloBMT Patients
ClinicalTrials.gov ID: NCT07457866
What this study is testing
- What it's testing
- The goals of this phase III clinical trial is to determine effectiveness in the setting where it will be implemented as well as to gain an understanding of the context for implementation. Effectiveness of CaRE-4-alloBMT will be assessed using a parallel two-arm pragmatic randomized controlled trial (pRCT).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- scheduled to undergo alloBMT and are:
- \> 18 years of age;
- receiving treatment for a hematologic cancer;
- completing pre- and post-transplant care at PM;
- able to access on-line study material; and
You likely can't join if
- scheduled to be admitted to the hospital for their alloBMT \< 2 weeks from the initial assessment booking, as this will not allow enough time for the...
- are participating in any other clinical trials or supportive care intervention studies; or
- have comorbidities or musculoskeletal complications that preclude participation in the exercise programs.
See the full eligibility criteria
- scheduled to undergo alloBMT and are:
- \> 18 years of age;
- receiving treatment for a hematologic cancer;
- completing pre- and post-transplant care at PM;
- able to access on-line study material; and
- able to understand (spoken and written) English. Participants receiving a second transplant at the time of screening will be included if they meet the above criteria.
- scheduled to be admitted to the hospital for their alloBMT \< 2 weeks from the initial assessment booking, as this will not allow enough time for the prehabilitation phase of the study;
- are participating in any other clinical trials or supportive care intervention studies; or
- have comorbidities or musculoskeletal complications that preclude participation in the exercise programs.
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.